MERIT MEDICAL SYSTEMS INC 8-K

What Happened
Merit Medical Systems, Inc. (MMSI) filed an 8‑K reporting results from its May 13, 2026 Annual Meeting and related board actions. Shareholders approved the Merit Medical Systems 2026 Equity Incentive Plan (EIP) and the 2026 Employee Stock Purchase Plan (ESPP). The board also adopted amended and restated bylaws on May 14, 2026 and approved a form Restricted Stock Unit Award Agreement for directors. The meeting ratified Deloitte & Touche LLP as the independent auditor for fiscal 2026 and elected four directors.

Key Details

• Meeting and turnout: Record date March 20, 2026; 59,648,292 shares entitled to vote; 52,532,073 shares represented at the Annual Meeting.
• Equity plans approved: EIP — For 48,750,003 / Against 1,510,844 / Abstain 7,962 (broker non‑votes 2,263,264). ESPP — For 50,109,861 / Against 151,208 / Abstain 7,740 (broker non‑votes 2,263,264).
• Director elections: Martha G. Aronson, Lonny J. Carpenter and Scott R. Ward elected for three‑year terms (until 2029); Lynne N. Ward elected for a one‑year term (until 2027). Example vote for Scott R. Ward: For 50,071,431 / Against 176,296 / Abstain 21,082 (BNN 2,263,264). A press release on May 19 announced Scott R. Ward’s election.
• Other votes: Advisory “say‑on‑pay” passed (For 48,835,995 / Against 1,415,355 / Abstain 17,459). Auditor ratified: Deloitte & Touche LLP (For 50,369,058 / Against 2,151,392 / Abstain 11,623).
• Director RSU agreement: Board approved a base form Restricted Stock Unit Award Agreement for directors; RSUs vest after 350 days of continuous service.
• Bylaws updated (effective May 14, 2026): permit remote participation and electronic notices, reflect universal proxy rules, allow certificated/uncertificated shares, modify officer composition, and align indemnification with the Utah Revised Business Corporation Act.

Why It Matters
Approval of the EIP and ESPP establishes the company’s 2026 equity‑based compensation framework, which can affect future dilution, executive/director incentive alignment, and employee ownership — items investors should monitor in proxy disclosures and future filings. The director RSU form clarifies how non‑employee directors will receive equity awards (vesting after 350 days). The updated bylaws modernize governance (remote participation, electronic notice, proxy rules) and may affect shareholder engagement and corporate governance procedures going forward. Ratification of Deloitte maintains continuity in external audit oversight.